September 2026
The direct-to-consumer laboratory testing market size is projected to hit around USD 8.69 billion by 2035 from USD 4.08 billion in 2026 with a CAGR of 8.77%.
August 2026
The direct-to-consumer genetic testing market reached USD 2.45 billion in 2026, featuring leading direct-to-consumer genetic testing companies such as Identigene, Karmagenes, Living DNA, Mapmygenome.
September 2026
The US direct-to-consumer laboratory testing market size was evaluated at USD 1.34 billion in 2026 and is predicted to hit around USD 2.92 billion by 2035, growing at a CAGR of 9.03%.